1. Home
  2. GDO vs APLT Comparison

GDO vs APLT Comparison

Compare GDO & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDO
  • APLT
  • Stock Information
  • Founded
  • GDO 2009
  • APLT 2016
  • Country
  • GDO United States
  • APLT United States
  • Employees
  • GDO N/A
  • APLT N/A
  • Industry
  • GDO Finance Companies
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDO Finance
  • APLT Health Care
  • Exchange
  • GDO Nasdaq
  • APLT Nasdaq
  • Market Cap
  • GDO 84.5M
  • APLT 80.3M
  • IPO Year
  • GDO N/A
  • APLT 2019
  • Fundamental
  • Price
  • GDO $11.47
  • APLT $0.65
  • Analyst Decision
  • GDO
  • APLT Buy
  • Analyst Count
  • GDO 0
  • APLT 7
  • Target Price
  • GDO N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • GDO 39.4K
  • APLT 3.6M
  • Earning Date
  • GDO 01-01-0001
  • APLT 03-05-2025
  • Dividend Yield
  • GDO 9.81%
  • APLT N/A
  • EPS Growth
  • GDO N/A
  • APLT N/A
  • EPS
  • GDO N/A
  • APLT N/A
  • Revenue
  • GDO N/A
  • APLT N/A
  • Revenue This Year
  • GDO N/A
  • APLT N/A
  • Revenue Next Year
  • GDO N/A
  • APLT $2,622.90
  • P/E Ratio
  • GDO N/A
  • APLT N/A
  • Revenue Growth
  • GDO N/A
  • APLT N/A
  • 52 Week Low
  • GDO $11.21
  • APLT $0.54
  • 52 Week High
  • GDO $13.04
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • GDO 61.08
  • APLT 35.67
  • Support Level
  • GDO $11.33
  • APLT $0.54
  • Resistance Level
  • GDO $11.49
  • APLT $0.66
  • Average True Range (ATR)
  • GDO 0.08
  • APLT 0.06
  • MACD
  • GDO 0.02
  • APLT 0.09
  • Stochastic Oscillator
  • GDO 90.00
  • APLT 81.26

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: